Applications of RNA from circulating tumor cells

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• Circulating tumor cells (CTCs) are crucial biomarkers for non-invasive cancer monitoring.
• RNA analysis of CTCs provides dynamic gene expression profiles for assessing tumor progression and treatment efficacy.
• Epithelial to Mesenchymal Transition (EMT) is a key process in metastasis, influencing CTC survival and clinical outcomes.

Purpose of the Study:

• To review RNA analysis techniques for CTCs.
• To explore the role of Epithelial to Mesenchymal Transition (EMT) in CTCs.
• To discuss the applications of CTC RNA analysis in cancer diagnosis, prognosis, and treatment guidance.

Main Methods:

• Droplet digital reverse transcription PCR (RT-ddPCR) for high-sensitivity RNA detection in CTCs.
• RNA sequencing (RNAseq) for comprehensive transcriptome analysis of CTCs.
• Single-cell RNA sequencing (scRNAseq) for assessing CTC heterogeneity and functional states.
• RNA in situ hybridization (RNA-ISH) for spatial gene expression analysis within individual CTCs.

Main Results:

• RNA analysis of CTCs, including gene expression profiling, significantly enhances their clinical and prognostic value.
• Monitoring dynamic changes in CTC RNA and EMT status can guide cancer treatment strategies.
• Various RNA analysis methods offer different levels of sensitivity, comprehensiveness, and resolution for CTC evaluation.

Conclusions:

• RNA analysis of CTCs, particularly focusing on EMT, holds significant potential for improving cancer diagnosis and prognosis.
• Advanced techniques like RT-ddPCR, RNAseq, and scRNAseq provide powerful tools for interrogating CTC biology.
• Further research into CTC RNA profiles and EMT dynamics is essential for optimizing cancer patient management.